Satsuma Pharmaceuticals, Inc. 3 SEC Filings

Filed On	Filing
16 Nov 2022	Form 3: Leonard Braden Michael, 10% owner Holds 5,608,306 shares of Common Stock
19 Oct 2021	Form 3: Commodore Capital Lp, 10% owner Holds 3,208,761 shares of Common Stock, par value $0.0001 per share
12 Oct 2021	Form 3: Harsch Mutya, Director No securities owned
07 Jul 2020	Form 3: Soloway Thomas P, Director No securities owned
18 Sep 2019	Form 3: Tpg Group Holdings (SBS) Advisors, Inc., 10% owner and 2 others
12 Sep 2019	Form 3: Hadley Harbor Master Investors (Cayman) Ii L.p., 10% owner
12 Sep 2019	Form 3: Ra Capital MANAGEMENT, Llc, Director and 2 others
12 Sep 2019	Form 3: Takanashi Ken, Director Holds 987,535 shares of Common Stock, $0.0001 par value
12 Sep 2019	Form 3: Riebe Michael T, Director
12 Sep 2019	Form 3: Shah Rajeev M., Director
12 Sep 2019	Form 3: Albrecht Detlef, Chief Medical Officer Holds 20,212 shares of Common Stock, $0.0001 par value
12 Sep 2019	Form 3: Kollins John A, Director Holds 305,911 shares of Common Stock, $0.0001 par value
12 Sep 2019	Form 3: Sandoval Elisabeth, Director
12 Sep 2019	Form 3: Lukatch Heath, Director No securities owned
12 Sep 2019	Form 3: King Thomas Braxton, Director
12 Sep 2019	Form 3: O'Neil Thomas P., Chief Financial Officer

Comments